Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells.
We introduce a protocol for generating 3D organoids from circulating tumor cells (CTCs), enabling longitudinal functional and molecular analyses in pancreatic cancer patients, including those with unr
APA
Tang J, Zheng Q, et al. (2025). Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells.. STAR protocols, 6(1), 103635. https://doi.org/10.1016/j.xpro.2025.103635
MLA
Tang J, et al.. "Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells.." STAR protocols, vol. 6, no. 1, 2025, pp. 103635.
PMID
39946239
Abstract
We introduce a protocol for generating 3D organoids from circulating tumor cells (CTCs), enabling longitudinal functional and molecular analyses in pancreatic cancer patients, including those with unresectable disease, which constitutes the majority of cases. We outline the process for isolating and characterizing CTCs from the blood of pancreatic cancer patients and provide detailed instructions for initiating, passaging, and phenotyping CTC-derived organoids. Additionally, we describe techniques for utilizing these organoids in drug screening with a focus on stemness-related pathways. For complete details on the use and execution of this protocol, please refer to Tang et al..
MeSH Terms
Humans; Neoplastic Cells, Circulating; Pancreatic Neoplasms; Organoids; Cell Culture Techniques, Three Dimensional; Cell Line, Tumor
같은 제1저자의 인용 많은 논문 (5)
- Association between the prognostic nutritional index and early mortality of AML patients after allogeneic HSCT: a retrospective cohort analysis.
- High-dimensional single-cell analysis evaluating effects of different airway management strategies on perioperative immune cells in non-small cell lung cancer surgery.
- Development and validation of an 11-CpG methylation signature-based nomogram for predicting prognosis in early-onset breast cancer.
- Development and validation of an immune-related diagnostic signature for breast cancer bone metastasis.
- USP7-mediated deubiquitination of the KEAP1-NRF2-HMOX1 axis enhances radioresistance in non-small cell lung cancer by suppressing ferroptosis.